Concordant with the findings that the GLP-1 receptor system is intimately involved in multiple aspects of the neurodegenerative axes of AD, PD, and HD, it is unsurprising that ligands that can target this receptor system have been demonstrated to exert multiple remedial and effective actions (168, 174–178). The gene discussed is GLP1R; the disease is Parkinson disease.